Reference Ranges Explained: A C Gets the Degree
Your reference range is a passing grade.
Would you want a surgeon who graduated with a C? A C passes. It gets the degree, the license and the white coat. Your lab report grades you the same way. It asks whether you passed, not whether you are well, and the line was drawn by people who never met you.
The tests are useful. The trouble is the bracket next to the number, which for most people decides whether they get treated at all.
What the bracket actually is
Measure something in a group of people's blood and plot the results as a bell curve. Throw away the lowest 2.5% and the highest 2.5%. The middle 95% is printed next to your result as the reference range. A 2018 paper titled "The normal range: it is not normal and it is not a range" says no underlying theory assumes that central 95% is physiologically normal.
The arithmetic follows. One healthy person in 20 gets flagged on any single test, by definition. On a panel of 20 tests, up to about two thirds of healthy people will see at least one flag. That assumes the tests are independent, which in real blood they are not entirely, so the true share is lower. A flag is an expected result of testing a healthy person.
If the range can flag a healthy person, landing inside it cannot certify that you are healthy. The range describes a crowd. It never described you.
Who drew the line, and from whose blood
In a 2007 survey of 163 labs, about half relied entirely on outside sources: the manufacturer's package insert, a textbook, another lab. Of those that drew people, about half tested 21 to 50, when the guideline for building a range calls for at least 120.
The same blood gets different verdicts. In a 2006 survey of 25 New England labs (older assays), a testosterone of 251 would read low at 14 of them and normal at the other 11. In September 2026, Quest prints a men's floor of 250, which its own website describes as the 2.5th percentile of healthy men up to age 90. Labcorp prints 264, drawn from healthy, non-obese men aged 19 to 39. A 55-year-old man gets either one printed as his range.
The line moves. Your body does not.
In September 2026, Labcorp lowered its vitamin D floor from 30 to 20. A result of 25 was flagged low one day and normal the next. In 2014 the lab serving Calgary lowered its TSH ceiling from 6 to 4 with no change to the test, and the share of abnormal results roughly tripled overnight. That line moved toward more treatment, and it was just as arbitrary.
The crowd may not be healthy either, and Labcorp's test page concedes as much: the approach "does not adequately determine health status with regard to vitamin D levels if a significant portion of the reference population is, in fact, deficient."
Sixty years of the field warning itself
The people who build these ranges have said so in their own journals since 1967, when a paper wrote that the normal range "provides information which is mostly irrelevant, and is largely ignored by the experienced clinician."
In 2002, 15 healthy men gave blood every month for a year. Each man's own TSH range was about half as wide as the group's. Two of them never overlapped at all, and both sat inside the lab's bracket. Their sentence belongs on every report: "a test result within laboratory reference limits is not necessarily normal for an individual."
That is how you can feel terrible with normal labs. If your free T3 ran at 4.5 your whole adult life and now runs at 3, you have lost a third of it, and every line is green. The only range that was ever about you is your own baseline.
"Normal for your age" is decline with a label on it
An age-adjusted range takes a crowd of people your age, many of them tired, heavier and sleeping badly, and prints its middle as your target. A 2014 review said such ranges "have the effect of normalising physiological decline."
In 2004, 52 men with diagnosed hypogonadism were followed as their testosterone implants wore off. Each man's symptoms came back at his own level, reproducibly, and the level varied widely between men. One printed floor pretends they share a line.
So for a man, symptoms lead. Pushed for a number, I want him at least above 1,000. That is my clinical position, not a study finding. After menopause, a woman with almost no estradiol is routinely told she is normal for her age. I want her at 75 or higher.
Normal versus optimal, marker by marker
Printed ranges are Quest or Labcorp, September 2026. The targets are mine, from practice, and none is a promise.
B12. Quest prints 200 to 1,100. In a diabetes prevention trial, 1 in 5 people with a B12 between about 200 and 300 already had a high homocysteine, a sign the cell may be running short. I want B12 above 1,000.
Vitamin D. The floor is 30 or 20 by lab, and in 2024 the Endocrine Society withdrew its own target of 30. In pooled prediabetes trials, people who reached 50 or more had about a 75% lower rate of progressing to diabetes than those at 20 to 29. That is an association by achieved level; the randomized result was 15% less diabetes. I aim for 90 to 100, with calcium checked.
Ferritin. Labcorp's floor for adult women is 15. Using bone marrow as the truth, the odds of iron deficiency do not start to fall until ferritin passes about 40, or about 70 with inflammation. My floor is 75.
SHBG. Quest's range for younger men tops out at 50. In a 2009 study, men in the top quarter, about 34 to 76, had about 90% lower odds of type 2 diabetes than the bottom quarter. It is an association, though genetic studies agree, and a high SHBG, printed in red, is the best news on the page. I want it close to 100.
ApoB, ApoA-1, triglycerides, HDL. ApoB under 90. ApoA-1 above 125. Triglycerides print as normal under 150; I want them under 50, with HDL above 60.
When the lab and the patient disagree, the patient wins
Symptoms dictate treatment. Labs do not. I use labs at baseline, to confirm absorption, and as safety gates: ferritin before restarting testosterone, calcium with a high vitamin D, a PSA before a man starts. Once someone is optimized, about once a year. Optimal medicine is knowing which numbers are gates and which are grades.
If you were told your labs are normal and you know you are not, stop apologizing for how you feel. Bring your history, and any old result from a year you felt well. Then change the question from "are my labs normal?" to "where would I need to be to feel like myself again?"
You passed. You got the C. You are allowed to want more than that.
The whole argument:
⚠️ Educational content, not individual medical advice or a treatment recommendation. Nobody should start, stop or change a prescription because of an article. Your labs and history belong in a one on one.
🩺 DNP led telehealth hormone optimization. Book a consultation and find everything: withinyou.health/links
Sources
Aberra, T., Peterson, E. D., Pagidipati, N. J., et al. (2020). The association between triglycerides and incident cardiovascular disease: what is 'optimal'? J Clin Lipidol, 14(4), 438-447.e3. https://doi.org/10.1016/j.jacl.2020.04.009
Ahima, R. S., & Flier, J. S. (2000). Leptin. Annu Rev Physiol, 62, 413-437.
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002). Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab, 87(3), 1068-1072. https://doi.org/10.1210/jcem.87.3.8165
Araujo, A. B., Esche, G. R., Kupelian, V., et al. (2007). Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab, 92(11), 4241-4247. https://doi.org/10.1210/jc.2007-1245
Aribas, E., Kavousi, M., Laven, J. S. E., Ikram, M. A., & Roeters van Lennep, J. E. (2021). Aging, cardiovascular risk, and SHBG levels in men and women from the general population. J Clin Endocrinol Metab, 106(10), 2890-2900. https://doi.org/10.1210/clinem/dgab470
Aroda, V. R., Edelstein, S. L., Goldberg, R. B., et al. (2016). Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab, 101(4), 1754-1761. https://doi.org/10.1210/jc.2015-3754
Bailey, D., MacDonald, L., & Monkman, H. (2024). What people know vs. what they should know about laboratory reference ranges. Stud Health Technol Inform, 316, 1089-1093. https://doi.org/10.3233/SHTI240599
Bates, C. J. (1999). Diagnosis and detection of vitamin deficiencies. Br Med Bull, 55(3), 643-657. https://doi.org/10.1258/0007142991902529
Belliveau, R. E., Fitzgerald, J. E., & Nickerson, D. A. (1970). Evaluation of routine profile chemistry screening of all patients admitted to a community hospital. Am J Clin Pathol, 53(4), 447-451. https://doi.org/10.1093/ajcp/53.4.447
Beutler, E., & Waalen, J. (2006). The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood, 107(5), 1747-1750. https://doi.org/10.1182/blood-2005-07-3046
Bhasin, S., Pencina, M., Jasuja, G. K., et al. (2011). Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab, 96(8), 2430-2439. https://doi.org/10.1210/jc.2010-3012
Bhasin, S., Brito, J. P., Cunningham, G. R., et al. (2018). Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 103(5), 1715-1744. https://doi.org/10.1210/jc.2018-00229
Blum, W. F., Englaro, P., Hanitsch, S., et al. (1997). Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab, 82(9), 2904-2910. https://doi.org/10.1210/jcem.82.9.4251
Boorse, C. (1997). A rebuttal on health. In J. M. Humber & R. F. Almeder (Eds.), What is disease? (pp. 1-134). Humana Press.
Brooks, G. A., Dubouchaud, H., Brown, M., Sicurello, J. P., & Butz, C. E. (1999). Role of mitochondrial lactate dehydrogenase and lactate oxidation in the intracellular lactate shuttle. Proc Natl Acad Sci USA, 96, 1129-1134.
Celi, F. S., Zemskova, M., Linderman, J. D., Smith, S., Drinkard, B., Sachdev, V., Skarulis, M. C., Kozlosky, M., Csako, G., Costello, R., & Pucino, F. (2011). Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. J Clin Endocrinol Metab, 96(11), 3466-3474. https://doi.org/10.1210/jc.2011-1329
Ceriotti, F., & Henny, J. (2008). 'Are my laboratory results normal?' Considerations to be made concerning reference intervals and decision limits. EJIFCC, 19(2), 106-114 (PMC4975205).
Chakhtoura, M., Bacha, D. S., Gharios, C., et al. (2022). Vitamin D supplementation and fractures in adults: a systematic umbrella review of meta-analyses of controlled trials. J Clin Endocrinol Metab, 107(3), 882-898. https://doi.org/10.1210/clinem/dgab742
Clinical and Laboratory Standards Institute. (2008). Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline (3rd ed., CLSI document EP28-A3c, formerly C28-A3; G. L. Horowitz, S. Altaie, J. C. Boyd, F. Ceriotti, et al.). CLSI.
Cromwell, W. C., Otvos, J. D., Keyes, M. J., et al. (2007). LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study: implications for LDL management. J Clin Lipidol, 1(6), 583-592. https://doi.org/10.1016/j.jacl.2007.10.001
Culver, B. H. (2012). How should the lower limit of the normal range be defined? Respir Care, 57(1), 136-145. https://doi.org/10.4187/respcare.01427
Demay, M. B., Pittas, A. G., Bikle, D. D., et al. (2024). Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 109(8), 1907-1947. https://doi.org/10.1210/clinem/dgae290
Desideri, G., Castaldo, G., Lombardi, A., et al. (2014). Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci, 18(9), 1295-1306.
Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2006). Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA, 295(11), 1288-1299. https://doi.org/10.1001/jama.295.11.1288
Ding, E. L., Song, Y., Manson, J. E., et al. (2009). Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med, 361(12), 1152-1163. https://doi.org/10.1056/NEJMoa0804381
Doles, W. M., et al. (2025). Interpretating normal values and reference ranges for laboratory tests. J Am Board Fam Med, 38(1), 174-179. https://doi.org/10.3122/jabfm.2024.240224R1
Doyle, K., & Bunch, D. R. (2023). Reference intervals: past, present, and future. Crit Rev Clin Lab Sci, 60(6), 466-482. https://doi.org/10.1080/10408363.2023.2196746
Elveback, L. R. (1973). The population of healthy persons as a source of reference information. Hum Pathol, 4(1), 9-16. https://doi.org/10.1016/s0046-8177(73)80042-5
Engin, A. (2017). Adiponectin-Resistance in Obesity. In A. B. Engin & A. Engin (Eds.), Obesity and lipotoxicity (Advances in Experimental Medicine and Biology, Vol. 960, pp. 415-441). Springer. https://doi.org/10.1007/978-3-319-48382-5_18
Fang, H., & Judd, R. L. (2018). Adiponectin Regulation and Function. Compr Physiol, 8, 1031-1063. https://doi.org/10.1002/cphy.c170046
Farhana, A., & Lappin, S. L. (2023). Biochemistry, Lactate Dehydrogenase. In StatPearls. StatPearls Publishing. Bookshelf ID NBK557536, PMID 32491468.
Fraser, C. G. (2004). Inherent biological variation and reference values. Clin Chem Lab Med, 42(7), 758-764. https://doi.org/10.1515/CCLM.2004.128
Fraser, C. G. (2012). Reference change values. Clin Chem Lab Med, 50(5), 807-812. https://doi.org/10.1515/CCLM.2011.733
Frederiksen, L., Højlund, K., Hougaard, D. M., et al. (2012). Testosterone therapy decreases subcutaneous fat and adiponectin in aging men. Eur J Endocrinol, 166(3), 469-476. https://doi.org/10.1530/EJE-11-0565
Friedberg, R. C., Souers, R., Wagar, E. A., Stankovic, A. K., & Valenstein, P. N. (2007). The origin of reference intervals: a College of American Pathologists Q-Probes study of normal ranges used in 163 clinical laboratories. Arch Pathol Lab Med, 131(3), 348-357. https://doi.org/10.5858/2007-131-348-TOORI
Glaser, R., & Dimitrakakis, C. (2021). Testosterone Implant Therapy in Women With and Without Breast Cancer: Rationale, Experience, Evidence. Androgens: Clinical Research and Therapeutics, 2(1), 100-113. https://doi.org/10.1089/andro.2021.0003
González, R. R., Simón, C., Caballero-Campo, P., Norman, R., Chardonnens, D., Devoto, L., & Bischof, P. (2000). Leptin and reproduction. Human Reproduction Update, 6(3), 290-300.
Guerre-Millo, M. (2008). Adiponectin: An update. Diabetes & Metabolism, 34, 12-18. https://doi.org/10.1016/j.diabet.2007.08.002
Guyatt, G. H., Oxman, A. D., Ali, M., Willan, A., McIlroy, W., & Patterson, C. (1992). Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med, 7(2), 145-153. https://doi.org/10.1007/BF02598003
Hallberg, L., Bengtsson, C., Lapidus, L., Lindstedt, G., Lundberg, P. A., & Hulten, L. (1993). Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol, 85(4), 787-798. https://doi.org/10.1111/j.1365-2141.1993.tb03225.x
Harris, E. K. (1974). Effects of intra- and interindividual variation on the appropriate use of normal ranges. Clin Chem, 20(12), 1535-1542.
Hershberg, P. I., Englebardt, C., Harrison, R., Rockart, J. F., & McGandy, R. B. (1971). The medical history question as a health screening test: an assessment of validity. Arch Intern Med, 127(2), 266-272.
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., et al. (2011). Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 96(7), 1911-1930. https://doi.org/10.1210/jc.2011-0385
Hollowell, J. G., Staehling, N. W., Flanders, W. D., et al. (2002). Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab, 87(2), 489-499. https://doi.org/10.1210/jcem.87.2.8182
Horowitz, G. L. (2008). Reference intervals: practical aspects. EJIFCC, 19(2), 95-105 (PMC4975204).
Houseknecht, K. L., Baile, C. A., Matteri, R. L., & Spurlock, M. E. (1998). The Biology of Leptin: A Review. J Anim Sci, 76, 1405-1420.
Institute of Medicine. (2011). Dietary reference intakes for calcium and vitamin D (A. C. Ross, C. L. Taylor, A. L. Yaktine, & H. B. Del Valle, Eds.). National Academies Press. https://doi.org/10.17226/13050
Jabbar, A., Yawar, A., Waseem, S., et al. (2008). Vitamin B12 deficiency common in primary hypothyroidism. J Pak Med Assoc, 58(5), 258-261.
Jockenhövel, F., Blum, W. F., Vogel, E., Englaro, P., Müller-Wieland, D., Reinwein, D., Rascher, W., & Krone, W. (1997). Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab, 82(8), 2510-2513.
Kadowaki, T., & Yamauchi, T. (2005). Adiponectin and Adiponectin Receptors. Endocrine Reviews, 26(3), 439-451. https://doi.org/10.1210/er.2005-0005
Katayev, A., Balciza, C., & Seccombe, D. W. (2010). Establishing reference intervals for clinical laboratory test results: is there a better way? Am J Clin Pathol, 133(2), 180-186. https://doi.org/10.1309/AJCPN5BMTSF1CDYP
Kelleher, S., Conway, A. J., & Handelsman, D. J. (2004). Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab, 89(8), 3813-3817. https://doi.org/10.1210/jc.2004-0143
Khan, A. A., Allemailem, K. S., Alhumaydhi, F. A., Gowder, S. J. T., & Rahmani, A. H. (2020). The Biochemical and Clinical Perspectives of Lactate Dehydrogenase: An Enzyme of Active Metabolism. Endocrine, Metabolic & Immune Disorders - Drug Targets, 20. https://doi.org/10.2174/1871530320666191230141110
Klein, R., Nagy, O., Tóthová, C., & Chovanová, F. (2020). Clinical and Diagnostic Significance of Lactate Dehydrogenase and Its Isoenzymes in Animals. Veterinary Medicine International, 2020, 5346483. https://doi.org/10.1155/2020/5346483
Kong, Z., Sun, S., Shi, Q., Zhang, H., Tong, T. K., & Nie, J. (2020). Short-term ketogenic diet improves abdominal obesity in overweight/obese Chinese young females. Front Physiol, 11, 856. https://doi.org/10.3389/fphys.2020.00856
Kraemer, R. R., Chu, H., & Castracane, V. D. (2002). Leptin and Exercise. Exp Biol Med, 227, 701-708.
Labcorp. (2017). Testosterone, total (Test 004226) and technical notice: Testosterone reference interval change for adult males. https://www.labcorp.com/tests/004226/testosterone-total
Labcorp. (2026). Vitamin D, 25-hydroxy (Test 081950) [Test page, updated September 15, 2026]. https://www.labcorp.com/tests/081950/vitamin-d-25-hydroxy
Laclaustra, M., Hurtado-Roca, Y., Sendin, M., et al. (2015). Lower-normal TSH is associated with better metabolic risk factors: a cross-sectional study on Spanish men. Nutr Metab Cardiovasc Dis, 25(12), 1095-1103. https://doi.org/10.1016/j.numecd.2015.09.007
Lawlor, D. A., Davey Smith, G., Ebrahim, S., Thompson, C., & Sattar, N. (2005). Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab, 90(10), 5677-5683. https://doi.org/10.1210/jc.2005-0825
Lazarou, S., Reyes-Vallejo, L., & Morgentaler, A. (2006). Wide variability in laboratory reference values for serum testosterone. J Sex Med, 3(6), 1085-1089. https://doi.org/10.1111/j.1743-6109.2006.00334.x
Le, T. N., Nestler, J. E., Strauss, J. F., & Wickham, E. P. (2012). Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab, 23(1), 32-40. https://doi.org/10.1016/j.tem.2011.09.005
Leese, G. P., & Flynn, R. V. (2012). The clinical impact of thyroid epidemiology. Clin Med (Lond), 12(Suppl 6), s64-s67.
Lerner, V., Kanevsky, M., Dwolatzky, T., Rouach, T., Kamin, R., & Miodownik, C. (2006). Vitamin B12 and folate serum levels in newly admitted psychiatric patients. Clin Nutr, 25(1), 60-67. https://doi.org/10.1016/j.clnu.2005.08.014
Liang, X., Liu, L., Fu, T., et al. (2016). Exercise inducible lactate dehydrogenase B regulates mitochondrial function in skeletal muscle. J Biol Chem, 291(49), 25306-25318. https://doi.org/10.1074/jbc.M116.749424
Lihn, A. S., Pedersen, S. B., & Richelsen, B. (2005). Adiponectin: action, regulation and association to insulin sensitivity. Obesity Reviews, 6, 13-21.
Lindenbaum, J., Healton, E. B., Savage, D. G., et al. (1988). Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med, 318(26), 1720-1728. https://doi.org/10.1056/NEJM198806303182604
Lindner, H. H. (2025). Clinical thyroidology: beyond the 1970s TSH-T4 paradigm. Front Endocrinol, 16, 1529791. https://doi.org/10.3389/fendo.2025.1529791
Linnebank, M., Moskau, S., Semmler, A., et al. (2011). Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol, 69(2), 352-359. https://doi.org/10.1002/ana.22229
Livingston, M., Downie, P., Hackett, G., Marrington, R., Heald, A., & Ramachandran, S. (2020). An audit of the measurement and reporting of male testosterone levels in UK clinical biochemistry laboratories. Int J Clin Pract, 74(11), e13607. https://doi.org/10.1111/ijcp.13607
Lokeshwar, S. D., Patel, P., Fantus, R. J., et al. (2020). Decline in serum testosterone levels among adolescent and young adult men in the USA. Eur Urol Focus, 7(4), 886-889. https://doi.org/10.1016/j.euf.2020.02.006
Lorde, N., Elgharably, A., & Kalaria, T. (2023). Impact of variation between assays and reference intervals in the diagnosis of endocrine disorders. Diagnostics (Basel), 13(22), 3453. https://doi.org/10.3390/diagnostics13223453
Mantzoros, C. S., Magkos, F., Brinkoetter, M., Sienkiewicz, E., Dardeno, T. A., Kim, S. Y., Hamnvik, O. P., & Koniaris, A. (2011). Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab, 301, E567-E584. https://doi.org/10.1152/ajpendo.00315.2011
Mast, A. E., Blinder, M. A., Gronowski, A. M., Chumley, C., & Scott, M. G. (1998). Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem, 44(1), 45-51.
McCullough, P. J., Lehrer, D. S., & Amend, J. (2019). Daily oral dosing of vitamin D3 using 5000 to 50,000 international units a day in long-term hospitalized patients: insights from a seven year experience. J Steroid Biochem Mol Biol, 189, 228-239. https://doi.org/10.1016/j.jsbmb.2018.12.010
Monferrer-Marín, J., Roldán, A., Monteagudo, P., & Blasco-Lafarga, C. (2022). Comment on: "Assessment of metabolic flexibility by means of measuring blood lactate, fat, and carbohydrate oxidation responses to exercise in professional endurance athletes and less-fit individuals". Sports Med, 52, 2009-2010. https://doi.org/10.1007/s40279-022-01659-2
Morgentaler, A. (2018). Current diagnostic criteria for testosterone deficiency are inadequate. Eur Urol Focus, 4(3), 348-350. https://doi.org/10.1016/j.euf.2018.08.014
Morris, Z. S., Wooding, S., & Grant, J. (2011). The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med, 104(12), 510-520. https://doi.org/10.1258/jrsm.2011.110180
Murphy, E. A., & Abbey, H. (1967). The normal range: a common misuse. J Chronic Dis, 20(2), 79-88. https://doi.org/10.1016/0021-9681(67)90099-9
Myers, M. G., Cowley, M. A., & Münzberg, H. (2008). Mechanisms of Leptin Action and Leptin Resistance. Annu Rev Physiol, 70, 537-556. https://doi.org/10.1146/annurev.physiol.70.113006.100707
O'Brien, P. C., & Dyck, P. J. (1995). Procedures for setting normal values. Neurology, 45(1), 17-23. https://doi.org/10.1212/WNL.45.1.17
Oh, D. K., Ciaraldi, T., & Henry, R. R. (2007). Adiponectin in health and disease. Diabetes, Obesity and Metabolism, 9, 282-289. https://doi.org/10.1111/j.1463-1326.2006.00610.x
Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y., & Libby, P. (2006). Adiponectin: a key adipocytokine in metabolic syndrome. Clinical Science, 110, 267-278. https://doi.org/10.1042/CS20050182
Ooi, D. S., Innanen, V. T., Wang, D., et al. (1998). Establishing reference intervals for DPC's free testosterone radioimmunoassay. Clin Biochem, 31(1), 15-21. https://doi.org/10.1016/s0009-9120(97)00143-4
Panov, A., Mayorov, V., Dikalov, S., Krasilnikova, A., & Yaguzhinsky, L. (2026). Rethinking Human Energy Metabolism. Curr Issues Mol Biol, 48, 159. https://doi.org/10.3390/cimb48020159
Passarella, S., de Bari, L., Valenti, D., Pizzuto, R., Paventi, G., & Atlante, A. (2008). Mitochondria and L-lactate metabolism. FEBS Letters, 582, 3569-3576. https://doi.org/10.1016/j.febslet.2008.09.042
Perry, J. R., Weedon, M. N., Langenberg, C., et al. (2010). Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet, 19(3), 535-544. https://doi.org/10.1093/hmg/ddp522
Perry, R. J., Zhang, X. M., Zhang, D., et al. (2014). Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis. Nat Med, 20(7), 759-763. https://doi.org/10.1038/nm.3579
Pfeiffer, C. M., Sternberg, M. R., Schleicher, R. L., Haynes, B. M. H., Rybak, M. E., & Pirkle, J. L. (2013). The CDC's Second National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population is a valuable tool for researchers and policy makers. J Nutr, 143(6), 938S-947S. https://doi.org/10.3945/jn.112.172858
Pittas, A. G., Kawahara, T., Jorde, R., et al. (2023). Vitamin D and risk for type 2 diabetes in people with prediabetes: a systematic review and meta-analysis of individual participant data from 3 randomized clinical trials. Ann Intern Med, 176(3), 355-363. https://doi.org/10.7326/M22-3018
Prati, D., Taioli, E., Zanella, A., et al. (2002). Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med, 137(1), 1-10. https://doi.org/10.7326/0003-4819-137-1-200207020-00006
Procaccini, C., Jirillo, E., & Matarese, G. (2012). Leptin as an immunomodulator. Molecular Aspects of Medicine, 33, 35-45. https://doi.org/10.1016/j.mam.2011.10.012
Pusparum, M., Ertaylan, G., & Thas, O. (2020). From population to subject-specific reference intervals. In V. V. Krzhizhanovskaya et al. (Eds.), Computational Science: ICCS 2020 (Lecture Notes in Computer Science, Vol. 12140, pp. 468-482). Springer. https://doi.org/10.1007/978-3-030-50423-6_35
Quest Diagnostics. (n.d.). FAQ165: Testosterone testing. Retrieved September 2026, from https://www.questdiagnostics.com/healthcare-professionals/clinical-education-center/faq/faq165
Quest Diagnostics. (2026). Test directory pages for tests 927, 17306, 92888, 457, 6399, 510, 30740, 5223, 5224, 608, 896, 593, 15060, 90367, 873 and 899, with Labcorp test pages 001503, 004598, 005009/005041, 082016, 016873, 167015, 001925/303756, 001172, 001115, 004650, 146712 and 004259. Retrieved September 24, 2026.
Riegelman, R. K. (1981). The limits of the laboratory: nuances of normality. Postgrad Med. https://doi.org/10.1080/00325481.1981.11715889
Ross, A. C., Manson, J. E., Abrams, S. A., et al. (2011). The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab, 96(1), 53-58. https://doi.org/10.1210/jc.2010-2704
Sánchez-Abarca, L. I., Tabernero, A., & Medina, J. M. (2001). Oligodendrocytes Use Lactate as a Source of Energy and as a Precursor of Lipids. Glia, 36(3), 321-329. https://doi.org/10.1002/glia.1119
San-Millán, I., & Brooks, G. A. (2018). Assessment of metabolic flexibility by means of measuring blood lactate, fat, and carbohydrate oxidation responses to exercise in professional endurance athletes and less-fit individuals. Sports Med, 48(2), 467-479. https://doi.org/10.1007/s40279-017-0751-x
Savage, D. G., Lindenbaum, J., Stabler, S. P., & Allen, R. H. (1994). Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med, 96(3), 239-246. https://doi.org/10.1016/0002-9343(94)90149-x
Sawin, C. T., Castelli, W. P., Hershman, J. M., McNamara, P., & Bacharach, P. (1985). The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med, 145(8), 1386-1388.
Sheikh, A., et al. (2018). TSH should not be used as a single marker of thyroid function. Ann Thyroid Res, 4(2).
Shimada, K., Miyazaki, T., & Daida, H. (2004). Adiponectin and atherosclerotic disease. Clinica Chimica Acta, 344, 1-12. https://doi.org/10.1016/j.cccn.2004.02.020
Sikaris, K. A. (2014). Physiology and its importance for reference intervals. Clin Biochem Rev, 35(1), 3-14 (PMC3961997).
Spiegel, K., Tasali, E., Penev, P., & Van Cauter, E. (2004). Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med, 141(11), 846-850. https://doi.org/10.7326/0003-4819-141-11-200412070-00008
Surks, M. I., Goswami, G., & Daniels, G. H. (2005). The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab, 90(9), 5489-5496. https://doi.org/10.1210/jc.2005-0170
Surks, M. I., & Hollowell, J. G. (2007). Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab, 92(12), 4575-4582. https://doi.org/10.1210/jc.2007-1499
Syed, E. U., Wasay, M., & Awan, S. (2013). Vitamin B12 supplementation in treating major depressive disorder: a randomized controlled trial. Open Neurol J, 7, 44-48. https://doi.org/10.2174/1874205X01307010044
Symonds, C., Kline, G., Gjata, I., Rose, M. S., Guo, M., Cooke, L., & Naugler, C. (2020). Levothyroxine prescribing and laboratory test use after a minor change in reference range for thyroid-stimulating hormone. CMAJ, 192(18), E469-E475. https://doi.org/10.1503/cmaj.191663
Thayakaran, R., Adderley, N. J., Sainsbury, C., et al. (2019). Thyroid replacement therapy, thyrotropin concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ, 366, l4892. https://doi.org/10.1136/bmj.l4892
Timbrell, N. E. (2024). The role and limitations of the reference interval within clinical chemistry and its reliability for disease detection. Br J Biomed Sci, 81, 12339. https://doi.org/10.3389/bjbs.2024.12339
Topliss, D. J. (2020). What happens when laboratory reference ranges change? CMAJ, 192(18), E481-E482. https://doi.org/10.1503/cmaj.200511
Travison, T. G., Araujo, A. B., O'Donnell, A. B., Kupelian, V., & McKinlay, J. B. (2007). A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab, 92(1), 196-202. https://doi.org/10.1210/jc.2006-1375
Travison, T. G., Vesper, H. W., Orwoll, E., et al. (2017). Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab, 102(4), 1161-1173. https://doi.org/10.1210/jc.2016-2935
Turer, A. T., & Scherer, P. E. (2012). Adiponectin: mechanistic insights and clinical implications. Diabetologia, 55, 2319-2326. https://doi.org/10.1007/s00125-012-2598-x
Vanderlinde, R. E. (1985). Measurement of Total Lactate Dehydrogenase Activity. Annals of Clinical and Laboratory Science, 15(1), 13-31.
Van Hall, G. (2000). Lactate as a fuel for mitochondrial respiration. Acta Physiol Scand, 168, 643-656.
Wabitsch, M., Blum, W. F., Muche, R., Braun, M., Hube, F., Rascher, W., Heinze, E., Teller, W., & Hauner, H. (1997). Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest, 100(4), 808-813.
Wallace, A. M., McMahon, A. D., Packard, C. J., Kelly, A., Shepherd, J., Gaw, A., & Sattar, N. (2001). Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation, 104(25), 3052-3056. https://doi.org/10.1161/hc5001.101061
Walldius, G., & Jungner, I. (2004). Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med, 255(2), 188-205. https://doi.org/10.1046/j.1365-2796.2003.01276.x
Walsh, B. W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V., & Sacks, F. M. (1991). Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med, 325(17), 1196-1204. https://doi.org/10.1056/NEJM199110243251702
Walsh, B. W., Li, H., & Sacks, F. M. (1994). Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res, 35(11), 2083-2093.
Walton, R. M. (2001). Establishing reference intervals: health as a relative concept. Semin Avian Exot Pet Med, 10(2), 66-71. https://doi.org/10.1053/saep.2001.22053
Wartofsky, L., & Dickey, R. A. (2005). The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab, 90(9), 5483-5488. https://doi.org/10.1210/jc.2005-0455
Weatherby, D., & DiLuglio, S. (n.d.). What is Optimal? Striving for Optimal Blood Chemistry Results and Optimal Health [White paper]. Optimal DX LLC.
Werner, M., & Marsh, W. L. (1975). Normal values: theoretical and practical aspects. CRC Crit Rev Clin Lab Sci, 6(2), 81-100. https://doi.org/10.3109/10408367509151566
Westgard, J. O., & Westgard, S. A. (2004). The truth about quality: medical usefulness and analytical reliability of laboratory tests. Clin Chim Acta, 346(1), 3-11. https://doi.org/10.1016/j.cccn.2003.12.034
WHO Scientific Group on Nutritional Anaemias. (1968). Nutritional anaemias: report of a WHO Scientific Group. World Health Organ Tech Rep Ser, 405, 5-37.
Whyte, M. B., & Kelly, P. (2018). The normal range: it is not normal and it is not a range. Postgrad Med J, 94(1117), 613-616. https://doi.org/10.1136/postgradmedj-2018-135983
Zhao, S., Kusminski, C. M., Elmquist, J. K., & Scherer, P. E. (2020). Leptin: Less Is More. Diabetes, 69, 823-829. https://doi.org/10.2337/dbi19-0018
Zitzmann, M., Faber, S., & Nieschlag, E. (2006). Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab, 91(11), 4335-4343. https://doi.org/10.1210/jc.2006-0401
Zyriax, B. C., Algenstaedt, P., Hess, U. F., et al. (2008). Factors contributing to the risk of cardiovascular disease reflected by plasma adiponectin: data from the coronary risk factors for atherosclerosis in women (CORA) study. Atherosclerosis, 200(2), 403-409. https://doi.org/10.1016/j.atherosclerosis.2007.12.033
